Tulbah, A. S. (2025). Formulation and in vitro characterization of inhalable dasatinib-nanoemulsion as a treatment potential against A549 and Calu-3 lung cancer cells. International Journal of Health Sciences, 19(1), 4–14. Retrieved from https://pub.qu.edu.sa/index.php/journal/article/view/8643